Posts by Sandra Ansanay-Alex
Food and Biotechnology Conference
The Food and Biotechnology Conference is taking place on 8-9 September 2026 in HES-SO Valais Wallis – Sion Organized by the Plant, Agriculture and Food Division of the European Federation of Biotechnology, this two-day event will bring together leading researchers, innovators, and industry professionals to explore the latest advances, trends, and breakthroughs in the field. Don’t miss this…
Read MoreSwissmedic approves donanemab for the treatment of early-stage Alzheimer’s disease
The drug, developed by Eli Lilly, slows the progression of the disease, but cannot stop or cure it. Alzheimer Switzerland and Swiss Memory Clinics welcome this decision, but emphasize that many people with Alzheimer’s disease and their families still face significant challenges. On February 4, 2026, the Swiss Agency for Therapeutic Products (Swissmedic) approved the…
Read MoreTissueLabs Spring School on Advanced Bioprinting
The TissueLabs Bioprinting Workshop is organised on 27 April 2026 in Bellinzona Step into the future of regenerative medicine at the TissueLabs Spring School on Advanced Bioprinting, a premier, hands-on training program designed for the next generation of bioengineers, scientists, and innovators. Over an intensive week, participants will master the full bioprinting workflow: from bioink…
Read MoreNoa Schmid gets the CSEM Inventor Award 2026
Micromechanical engineer Noa Schmid has been awarded the CSEM Inventor Award 2026 in recognition of his foundational contributions to precision liquid-handling technologies—key components of modern laboratory automation, diagnostics, and health monitoring. Over more than two decades at CSEM, Noa Schmid has played a central role in advancing devices capable of controlling and dispensing liquids at…
Read MoreGeorge Coukos appointed director of new Ludwig Laboratory for Cell Therapy in New York
The Ludwig Institute for Cancer Research has established the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine’s Sandra and Edward Meyer Cancer Center. The laboratory is directed by former Head of CHUV Oncology Department and Ludwig Lausanne Director George Coukos, a physician-scientist and global authority on tumor immunology and cellular immunotherapy. George Coukos returns…
Read MoreSwiss Biotech HemostOD Secures CHF 2 Million Innosuisse Grant to Advance Universal Platelet Technology
Swiss Health Valley biotech company HemostOD has been awarded a CHF 2 million competitive grant from Innosuisse, the Swiss Innovation Agency, to support key development milestones for its groundbreaking platelet manufacturing platform. The non-dilutive funding will play a pivotal role in strengthening HemostOD’s financial position as it moves towards major value-inflection points, including progressing toward…
Read MoreGivaudan Invests USD 110 Million in New Fragrance Facility in Mexico
Givaudan has announced a strategic investment of USD 110 million to build a new fragrance compounding facility in Pedro Escobedo, Mexico, reinforcing its presence in Latin America and supporting its long-term growth ambitions under the company’s 2030 strategy. The new site will operate under Givaudan’s “in the region, for the region” supply model, bringing production…
Read MoreTech4Eva Concludes After Five Years of Advancing Women’s Health Innovation
After five years of fostering innovation in women’s health, the Tech4Eva programme—co-founded by EPFL Innovation Park and Groupe Mutuel—will officially come to an end in 2026. Launched as a pioneering Femtech accelerator, Tech4Eva has grown into an internationally recognized exchange platform connecting entrepreneurs, researchers, corporates, and healthcare professionals with a shared mission: improving women’s health…
Read MoreProf. Bloch and Prof. Courtine Honored with the Queen Elizabeth Prize for Engineering 2026
The Queen Elizabeth Prize for Engineering 2026 has been awarded to Jocelyne Bloch, Head of Neurosurgery at the CHUV and professor at the Université de Lausanne, together with Grégoire Courtine, professor at the EPFL. The award recognizes their pioneering work in developing electronic spinal cord stimulation technologies that restore motor functions in people with spinal…
Read MoreEPFL and UNIL Co-Lead Three New National Research Poles for 2026–2029
For the 2026–2029 period, Switzerland has selected three major National Research Poles (PRN/NCCR) involving scientists from the Université de Lausanne and EPFL. These ambitious programmes address some of the most fundamental and urgent scientific challenges: the origins of life, the fight against childhood cancer, and separation sciences. Genesis: understanding the origins of lifeCo-hosted by the…
Read More